Corbus Pharmaceuticals Holding
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 581.2% | 1,432.2% | 492.1% | 1,645.9% | 706.1% | – | 1,027.5% | 1,201.9% | 1,174.1% | 818.8% | 1,155.2% | 76.2% | 855.4% | 912.7% | 1,359.1% | 10,716.4% | 2,236.5% | 2,447.6% | 1,654.9% | 8,249.4% | 8,544.4% | – | – | – | – | – | – | – | – | 11.0% | – | – | – | 20.8% | – | – | – | – | – | – | – | |
| -481.2% | -1,332.2% | -392.1% | -1,545.9% | -606.1% | – | -927.5% | -1,101.9% | -1,074.1% | -718.8% | -1,055.2% | 23.8% | -755.4% | -812.7% | -1,259.1% | 100.0% | -2,136.5% | -2,347.6% | -1,554.9% | -8,149.4% | -8,444.4% | – | – | – | – | – | – | – | – | -11.0% | – | – | – | -20.8% | – | – | – | – | – | – | – | |
| 581.2% | 1,432.2% | 492.1% | 1,645.9% | 706.1% | – | 1,027.5% | 1,201.9% | 1,174.1% | 818.8% | 1,155.2% | 76.2% | 855.4% | 912.7% | 1,359.1% | 10,716.4% | 2,236.5% | 2,447.6% | 1,654.9% | 8,249.4% | 8,934.8% | – | – | – | – | – | – | – | – | 517.1% | – | – | – | 1,249.3% | – | – | – | – | – | – | – | |
| 237.1% | 683.6% | 184.0% | 536.3% | 267.6% | – | 320.9% | 350.0% | 291.6% | 193.9% | 351.3% | 17.9% | 213.7% | 275.5% | 437.0% | 2,702.7% | 624.2% | 814.4% | 824.5% | 4,080.6% | 5,190.0% | – | – | – | – | – | – | – | – | 231.4% | – | – | – | 542.8% | – | – | – | – | – | – | – | |
| 818.3% | 2,115.7% | 676.1% | 2,182.2% | 973.6% | – | 1,348.4% | 1,551.9% | 1,465.7% | 1,012.7% | 1,506.5% | 94.1% | 1,069.1% | 243.9% | 437.0% | 13,419.1% | 624.2% | 814.4% | 824.5% | 4,080.6% | 5,812.7% | – | – | – | – | – | – | – | – | 737.6% | – | – | – | 1,771.3% | – | – | – | – | – | – | – | |
| -718.3% | -2,015.7% | -576.1% | -2,082.2% | -873.6% | – | -1,248.4% | -1,451.9% | -1,365.7% | -912.7% | -1,406.5% | 5.9% | -969.1% | -1,056.5% | -1,696.0% | -13,319.1% | -2,760.7% | -3,162.0% | -2,379.4% | -12,230.0% | -14,257.1% | – | – | – | – | – | – | – | – | -748.5% | – | – | – | -1,792.1% | – | – | – | – | – | – | – | |
| 0.2% | 1.7% | 0.1% | 1.5% | 5.5% | – | 21.4% | 31.2% | 24.6% | 12.7% | 17.7% | 1.5% | 11.3% | – | 5.8% | 4.4% | 36.9% | 225.3% | 99.8% | 293.8% | 402.6% | – | – | – | – | – | – | – | – | 52.4% | – | – | – | 94.1% | – | – | – | – | – | – | – | |
| -720.0% | -2,015.1% | -577.1% | -2,083.7% | -874.7% | – | -1,230.5% | -1,413.9% | -1,338.5% | -897.9% | -1,391.3% | 7.4% | -802.8% | -1,032.9% | -1,683.1% | -13,307.4% | -2,835.6% | -1,308.4% | -2,479.9% | -12,550.3% | -2,236.0% | – | – | – | – | – | – | – | – | -594.3% | – | – | – | -1,354.9% | – | – | – | – | – | – | – | |
| 1.8% | -0.6% | 1.0% | 1.5% | 1.1% | – | -17.8% | -38.0% | -27.2% | -22.8% | -15.3% | -1.5% | -7.6% | -21.1% | -13.0% | -172.6% | 74.5% | 96.6% | 98.2% | 153.6% | 343.0% | – | – | – | – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -720.0% | -2,015.1% | -577.1% | -2,083.7% | -874.7% | – | -1,230.5% | -1,413.9% | -1,338.5% | -897.9% | -1,391.3% | 7.4% | -802.8% | -1,032.9% | -1,683.1% | -13,307.4% | -2,835.6% | -1,308.4% | -2,479.9% | -12,550.3% | -2,236.0% | – | – | – | – | – | – | – | – | -594.3% | – | – | – | -1,354.9% | – | – | – | – | – | – | – | |
| -715.5% | -2,007.7% | -573.6% | -2,072.8% | -857.7% | – | -1,239.7% | -1,437.3% | -1,353.6% | -904.7% | -1,398.4% | 6.9% | -958.1% | -1,045.9% | -1,677.9% | -13,158.1% | -2,744.3% | -3,119.1% | -2,337.4% | -12,063.4% | -13,371.1% | – | – | – | – | – | – | – | – | -530.9% | – | – | – | -1,334.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.